These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 2196143)

  • 21. Five-year, multicenter study of a triphasic, low-dose, combination oral contraceptive.
    Woutersz TB; Korba VD
    Int J Fertil; 1988; 33(6):406-10. PubMed ID: 2906915
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma levels of ethinylestradiol (EE) during cyclic treatment with combined oral contraceptives.
    Kaufman JM; Thiery M; Vermeulen A
    Contraception; 1981 Nov; 24(5):589-602. PubMed ID: 7318439
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lipids and blood coagulation studies in women using steroidal hormones for contraception.
    Hashmi JA; Kazi AB; Kazi A; Ali N
    J Pak Med Assoc (1951); 1972 Aug; 22(8):218-25. PubMed ID: 12305803
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Absence of an effect of high vitamin C dosage on the systemic availability of ethinyl estradiol in women using a combination oral contraceptive.
    Zamah NM; Hümpel M; Kuhnz W; Louton T; Rafferty J; Back DJ
    Contraception; 1993 Oct; 48(4):377-91. PubMed ID: 8222665
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effect of an oral contraceptive (ethinylestradiol/D-norgestrel) on growth hormone and insulin secretion].
    Hausmann L; Goebel KM; Zehner J
    Schweiz Med Wochenschr; 1976 Oct; 106(43):1470-4. PubMed ID: 1013665
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bioequivalence of two oral contraceptive drugs containing norethindrone and ethinyl estradiol.
    Saperstein S; Edgren RA; Lee GJ; Jung D; Fratis A; Kushinsky S; Mroszczak E; Dorr A
    Contraception; 1989 Nov; 40(5):581-90. PubMed ID: 2612166
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of synthetic oestrogens and progestagens in oral contraceptives on bile lipid composition.
    Down RH; Whiting MJ; Watts JM; Jones W
    Gut; 1983 Mar; 24(3):253-9. PubMed ID: 6826111
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Presence of ethynyl-estradiol (EE-2) in blood and endometrium after interrupting steroidal contraception for three months.
    Sojo-Aranda I; Carranco-López A; Cortés-Gallegos V
    Contraception; 1987 Nov; 36(5):535-40. PubMed ID: 3447814
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of oral contraceptive on alpha I-antitrypsin activity.
    Kishore N; Rizvi V; Kishore N; Sharma BB
    J Obstet Gynaecol India; 1979 Apr; 29(2):259-60. PubMed ID: 12335890
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The bioavailability of ethinyloestradiol and levonorgestrel in patients with an ileostomy.
    Grimmer SF; Back DJ; Orme ML; Cowie A; Gilmore I; Tjia J
    Contraception; 1986 Jan; 33(1):51-9. PubMed ID: 3082591
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Paracetamol interaction with oral contraceptive steroids: increased plasma concentrations of ethinyloestradiol.
    Rogers SM; Back DJ; Stevenson PJ; Grimmer SF; Orme ML
    Br J Clin Pharmacol; 1987 Jun; 23(6):721-5. PubMed ID: 3111513
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative trials of low-dose combined oral contraceptives.
    Edelman DA; Kothenbeutel R; Levinski MJ; Kelly SE
    J Reprod Med; 1983 Mar; 28(3):195-200. PubMed ID: 6854550
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of tolterodine on the pharmacokinetics and pharmacodynamics of a combination oral contraceptive containing ethinyl estradiol and levonorgestrel.
    Olsson B; Landgren BM
    Clin Ther; 2001 Nov; 23(11):1876-88. PubMed ID: 11768839
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gastrointestinal metabolism of contraceptive steroids.
    Back DJ; Madden S; Orme ML
    Am J Obstet Gynecol; 1990 Dec; 163(6 Pt 2):2138-45. PubMed ID: 2147818
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Some observations on the changes in capillary resistance in oral contraceptive users.
    Zaki K; Younis MN; Razek SA; Mekkawi TE; Nour H
    Egypt Popul Fam Plann Rev; 1972 Jun; 5(1):145-51. PubMed ID: 12256025
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of contraceptive steroids on creatine kinase activity in serum.
    Gupta U; Gupta RC
    Clin Chem; 1982 Jun; 28(6):1402-3. PubMed ID: 7074957
    [No Abstract]   [Full Text] [Related]  

  • 37. Dolutegravir Has No Effect on the Pharmacokinetics of Oral Contraceptives With Norgestimate and Ethinyl Estradiol.
    Song IH; Borland J; Chen S; Wajima T; Peppercorn AF; Piscitelli SC
    Ann Pharmacother; 2015 Jul; 49(7):784-9. PubMed ID: 25862012
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Levetiracetam does not alter the pharmacokinetics of an oral contraceptive in healthy women.
    Ragueneau-Majlessi I; Levy RH; Janik F
    Epilepsia; 2002 Jul; 43(7):697-702. PubMed ID: 12102671
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Desogestrel- and levonorgestrel-containing oral contraceptives have different effects on urinary excretion of prostacyclin metabolites and serum high density lipoproteins.
    Ylikorkala O; Kuusi T; Tikkanen MJ; Viinikka L
    J Clin Endocrinol Metab; 1987 Dec; 65(6):1238-42. PubMed ID: 2960690
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oral contraceptives containing 20 or 30 micrograms ethinylestradiol and 150 micrograms desogestrel: pharmacokinetics and pharmacodynamic parameters.
    Jung-Hoffmann C; Fitzner M; Kuhl H
    Horm Res; 1991; 36(5-6):238-46. PubMed ID: 1823082
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.